• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Weekly Roundup: October 19-23


ICYMI, some of the content featured this week includes a new episode of our podcast focusing on telemedicine use in dermatology, female representation within the dermatological surgery space, pulsed dye laser and botulinumtoxinA as a combination treatment for rosacea, plus more.

In case you missed it, some of this week’s featured content includes a new episode of our podcast, The Cutaneous Connection, exploring telemedicine use in dermatology. We also published content about negotiating better managed care contracts, female representation within the dermatological surgery space, pulsed dye laser and botulinumtoxinA as a combination treatment for rosacea, nano-pulse stimulation for treatment of nodular basal cell carcinoma and cutaneous, non-genital warts, plus more.

Selling your practice: The due diligence, legal documentation and final negotiation phases

Todd Petersen, CEO of VitalSkin Dermatology, covers the ins and outs of the due diligence, legal documentation and final negotiation stages of selling a practice.

Negotiating better managed care contracts

Jerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares steps you can take and ways you can educate yourself in order to negotiate better managed care contracts.

The Mainstream Patient: October 20

This week’s edition of The Mainstream Patient features stories about postpartum hair loss, vitamin C benefits, witch hazel, fraxel laser treatments, isotretinoin’s effect on both the skin and mind, oily skin myths, plus more.

Older adults underrepresented in atopic dermatitis research

A recent review reveals older adults are underrepresented in trials investigating systemic immunomodulators as a treatment for atopic dermatitis.

Dupilumab provides option for severe AD in younger children

In a recent phase 3 trial, dupilumab (Dupixent, Sanofi and Regeneron) demonstrated positive results in itch reduction, skin clearance and quality-of-life. Indicating the biologic as a viable treatment option for severe atopic dermatitis in younger children.

Trial compares NMSC destructive techniques

A recent study showed that curettage and cryotherapy, and electrodesiccation and curettage are two techniques that have comparable cure rates. The study’s findings highlight the efficacy and reliability of these treatment approaches for minimally invasive cutaneous carcinomas.

Women surgeons and Mohs micrographic surgery in the U.S.

Michelle Nguyen, M.D., MPH, sits down with Dermatology Times to discuss her recent presentation at the 2020 American Society for Dermatologic Surgery (ASDS) virtual meeting regarding the representation of women dermatologic surgeons in the U.S.

PDL, botulinumtoxinA improves rosacea symptoms

Treatment with a pulsed dye laser followed immediately by intradermal botulinumtoxinA injections appears safe and improved erythema, flushing, burning and pruritus, according to a recent study.

The Cutaneous Connection- Episode 9: Telemedicine Use in Dermatology

Michael Sherling, M.D., practicing dermatologist and chief medical and strategy officer at Modernizing Medicine, discusses the recent rise in telemedicine use in dermatology, the benefits and detriments, as well as the future for the industry.

Nano-pulse stimulation shows positive results

Promising outcomes are being reported from clinical trials investigating nano-pulse stimulation technology to treat nodular basal cell carcinoma and cutaneous, non-genital warts.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.